[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"University of Montana\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":301},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,10,0,[8,43,76,107,134,164,191,219,249,280],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100633839","evaluating-the-feasibility-and-reliability-of-using-handheld-nebulizers-to-conduct-cough-sensitivity-testing-with-citric-acid-100633839",false,"NCT07531901","Evaluating the Feasibility and Reliability of Using Handheld Nebulizers to Conduct Cough Sensitivity Testing With Citric Acid","Inclusion Criteria:\n\n* Healthy adults at least 18 years of age\n* Consent to audio\u002Fvideo recording of the research sessions for research purposes\n* Spirometry testing results obtained by study team on same day of first testing session with FEV1\u002FFVC ratio and FEV1 percent predicted values of at least 0.70\n\nExclusion Criteria:\n\n* Pregnant or trying to become pregnant (if capable of becoming pregnant- a urine pregnancy test will be provided onsite and a negative result must be obtained prior to the first testing session)\n* Smoking of any substance in the last six months\n* Diagnosed or suspected pulmonary disease (e.g., asthma, COPD)\n* History of chronic cough\n* History of head or neck cancer\n* History of neurological disease (e.g., cerebrovascular accident)\n* History of dysphagia (swallowing difficulty)\n* Current complaint of a voice problem\n* Current upper respiratory infection",true,"ALL","18 Years","89 Years",{"count":5,"type":20},"ESTIMATED","INTERVENTIONAL",[23],"NA","Objective cough reflex sensitivity testing is typically restricted to specialized research laboratories due to reliance on expensive dosimeter-controlled aerosol delivery systems. This study evaluates the feasibility and reliability of a low-cost alternative method using a handheld nebulizer for citric acid cough challenge testing. Healthy adult participants will complete cough reflex sensitivity testing using both a standard dosimeter-controlled nebulizer system (Cosmed QuarkSpiro) and a handheld nebulizer (DeVilbiss 45). The study will compare cough threshold outcomes between methods to determine whether handheld nebulizer-based testing produces comparable and reproducible measurements.",[26],"Cough Reflex Sensitivity",[28,29],"cough challenge testing","cough reflex sensitivity testing","RECRUITING","2026-06-01",{"date":33,"type":34},"2026-06-03","ACTUAL",{"date":36,"type":20},"2026-06-05",{"date":38,"type":20},"2027-02-28",{"name":40,"class":41},"University of Montana","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":21,"phases":53,"briefSummary":55,"conditions":56,"keywords":60,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":69,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":75},"100589926","phase-2-mechanisms-of-change-in-behavioral-cough-suppression-therapy-for-refractory-chronic-cough-100589926","NCT06960759","Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough","CoughLESS","INCLUSION CRITERIA\n\nTo be eligible to participate, participants must meet the following criteria:\n\n* 18 - 99 years of age\n* Diagnosis of refractory or unexplained chronic cough\n* Normal chest imaging (x-ray or CT scan) within past 2 years, without change in cough symptoms\n* If you a potential participant has asthma, the following criteria must be met:\n\n  * Asthma diagnosed by a pulmonary provider\n  * Documentation from a pulmonary provider that asthma is well-controlled\n  * Agree to carry prescribed rescue inhaler to each study visit\n  * Can tolerate, and agree to, avoid rescue inhaler use for 4 hours prior to each study visit. If rescue inhaler use is unavoidable within 4 hours of a study visit, agree to inform researchers in advance so that the session can be rescheduled.\n* Normal pulmonary function testing with spirometry (FEV1\u002FFVC of at least 70% if diagnosed with asthma) within 2 years (6 months for those with a diagnosis of asthma), without change in symptoms since (NOTE: spirometry is included as part of cough threshold testing and can serve as this criteria if the participant has not had spirometry within the designated time.)\n* Laryngoscopy or stroboscopy within 2 years without evidence of structural pathology and no change in vocal quality since exam\n* Proficient reader\u002Fspeaker of English\n* Willing to take a pregnancy test before enrollment (if applicable)\n* Willing to use contraception during the study (if applicable)\n* Access to reliable internet, working email address (for surveys) and a smart phone (for use with CoughMonitor Watch)\n* Demonstrates understanding in study procedures and risks in order to consent\n* Available, and willing, to comply to all study procedures and clinic visits.\n\nEXCLUSION CRITERIA\n\nAny of the following will be grounds for exclusion from the study:\n\n* Currently a smoker of any substance or has a positive history of smoking any substance within the last 6 months\n* Currently suffering from any signs of an upper respiratory infection (other than cough)\n* Hemoptysis (coughing up blood) within the last 6 months\n* Pulmonary diagnosis other than asthma\n* Asthma criteria - participant is deemed ineligible if screened for one or more of the following:\n\n  * Use of rescue inhaler in response to active asthma symptoms ≥ 2 times per week\n  * Respiratory related emergency department visit within the past 4 weeks\n  * Respiratory related ICU admission within the past 12 months\n  * Asthma exacerbation requiring systemic corticosteroid use within the past 4 weeks\n* Pregnant or trying to become pregnant\n* Any complaints or clinical symptoms of dysphagia\n* Live with someone with chronic cough or work with someone with chronic cough who is in close proximity (e.g., within 25 feet) on a daily or nearly daily basis\n* Known allergy to peppers\n* Currently receiving or has received BCS therapy for management of refractory chronic cough\n* Excluded concomitant medications:\n\n  * Inhaled pulmonary medications (inhaled corticosteroids, short-acting beta agonists, long-acting beta-agonist, short-acting muscarinic antagonists), unless prescribed for asthma by pulmonary provider: 30 days prior to Visit 1 through completion of study participation\n  * ACE inhibitor (benazepril, captopril, enalapril, fosiniopril, lisinopril, perindopril, quinapril, ramipril, trandolapril): 30 days prior to Visit 1 through completion of study participation.\n  * Narcotic antitussive (hydrocodone, oxycodone, morphine, codeine, tramadol): 7 days prior to Visit 1 through completion of study participation\n  * Non-narcotic antitussive (benzonatate\u002FTessalon, dextromethorphan\u002FDelsym, carbetapentane\u002FSolotuss): 7 days prior to Visit 1 through completion of study\n  * P2X3 receptor antagonist (gefapixant\u002FLyfnua): 14 days prior to Visit 1 through completion of study\n  * Any off-label prescription medication prescribed for cough (pregabalin\u002FLyrica, gabapentin\u002FNeurontin, amitriptyline\u002FElavil): 14 days prior to Visit 1 through completion of study \\*if a neuromodulator is prescribed for something other than cough, participant must be on a stable dose for a minimum of 7 days\n\nThe following additional exclusion criteria will apply to participants who will undergo fMRI:\n\n* Presence of metal implants, devices or fragments (e.g., shrapnel) in the body\n* Claustrophobia","99 Years",{"count":52,"type":20},135,[54],"PHASE2","This study is testing new ways to help people who have chronic cough that has not improved with typical treatments. One approach is called behavioral cough suppression (BCS) therapy, which teaches people techniques to stop themselves from coughing. Another approach uses a natural substance thought to help reduce the body's sensitivity to cough triggers.\n\nIn this study, we will test two treatments and include one no-treatment control group. The control group will undergo baseline testing, cough monitoring, and an fMRI brain scan and will be offered BCS at end of study participation.\n\nThe two treatments include:\n\n* BCS therapy with active inhaled treatment (BCS+active),\n* BCS therapy with inactive inhaled treatment (BCS+inactive),\n\nThe investigators will enroll 135 adults with refractory chronic cough (RCC). 100 participants who qualify and are willing and able to complete 14 study visits in the clinic and two online study visits will be randomly assigned to one of the two treatments. The no-treatment control group (n=35) will be recruited from adults with RCC who are willing to complete baseline testing and fMRI but are not able or willing to attend 14 study clinic visits. These participants will not be randomized.\n\nThe investigators want to find out how these treatments affect:\n\n* How sensitive someone is to things that make them cough,\n* How well they can hold back a cough when they try,\n* How their brain responds to things that cause an urge-to-cough,\n* And how much their coughing affects their quality of life.\n\nThe investigators believe both treatments will reduce sensitivity to cough stimulants, reduce cough severity, and improve quality of life, but BCS+active inhaled treatment will work better than BCS+inactive inhaled treatment.",[57,58,59],"Chronic Cough (CC)","Refractory Chronic Cough","Unexplained Chronic Cough",[61,62,63,64,65,66,67],"cough hypersensitivity syndrome","randomized control trial","neurogenic cough","refractory chronic cough","unexplained chronic cough","chronic cough","behavioral cough suppression therapy","NOT_YET_RECRUITING",{"date":33,"type":34},{"date":71,"type":20},"2026-06-29",{"date":73,"type":20},"2030-03-31",{"name":40,"class":41},3,{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":80,"acronym":4,"eligibilityCriteria":81,"healthyVolunteers":11,"sex":16,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":4,"studyType":21,"phases":86,"briefSummary":87,"conditions":88,"keywords":90,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":99,"lastUpdatePostDateStruct":100,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":42},"100584308","physical-therapy-for-montana-children-with-nmd-using-hippotherapy-and-the-equine-environment-100584308","NCT06887647","Physical Therapy for Montana Children With NMD Using Hippotherapy and the Equine Environment","Inclusion Criteria:\n\n* 1\\) 6-17 years old; 2) Diagnosed NMD with upper extremity impairment; 3) Able to follow simple verbal instructions in English; 4) Able to tolerate sitting on a horse continuously for 30 minutes; and 5) Meet Professional Association of Therapeutic Horsemanship International (PATH Intl.) standards for participating in mounted activities.\n\nExclusion Criteria:\n\n* 1\\) Fear of or aversion to horses; 2) Weight over 200lbs (to protect safety and wellbeing of therapists and equines) 3) Participation in a horseback-riding program in the past 3 months; 4) Lacking independent head control; and 5) Caregivers unable to speak and read English.","6 Years","17 Years",{"count":85,"type":20},24,[23],"The goal of this pilot clinical trial is to determine if physical therapy incorporating horses can improve the motor skills of the arms in children 6-17 years old with neuromotor disorders (such as cerebral palsy, spinal muscular atrophy, or spina bifida) compared to standard play-based physical therapy. The main questions it aims to answer are:\n\n1. Is the study protocol feasible and acceptable for participants, that investigators could apply them to a larger trial?\n2. Do participants make improvements toward their goals for motor function, arm use, and participation in life situations following treatment, and is it different between the experimental and comparative intervention groups?\n3. What are the physiological, behavioral, and emotional responses of children receiving physical therapy incorporating horses, versus those receiving standard physical therapy?\n\nResearchers will compare the experimental group who receive physical therapy incorporating horses to the comparative intervention group who receive standard play-based physical therapy to see if there is a difference in outcomes.\n\nParticipants will complete a pre- and post-intervention assessment of their motor function and participation in life situations. Participants will receive physical therapy twice a week for 8 weeks for the intervention. In both groups, physiological, behavioral, and emotional responses to the interventions will be measured in 4 total sessions, 1 each at weeks 2, 4, 6, and 8.",[89],"Neuromotor Impairments",[91,92,93,94,95,96,97,98],"physical therapy","hippotherapy","pediatric","motor function","participation","upper extremity function","equine environment","neurmotor disorder","2026-05-11",{"date":101,"type":34},"2026-05-14",{"date":103,"type":34},"2025-08-20",{"date":105,"type":20},"2027-04-30",{"name":40,"class":41},{"id":108,"slug":109,"hasResults":11,"nctId":110,"briefTitle":111,"officialTitle":111,"acronym":4,"eligibilityCriteria":112,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":113,"enrollmentInfo":114,"targetDuration":4,"studyType":21,"phases":116,"briefSummary":117,"conditions":118,"keywords":123,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":126,"lastUpdatePostDateStruct":127,"startDateStruct":129,"completionDateStruct":131,"leadSponsor":133,"locationsCount":4},"100576657","enhancing-social-connections-among-rural-community-members-with-disordered-eating-100576657","NCT06788145","Enhancing Social Connections Among Rural Community Members With Disordered Eating","Inclusion Criteria:\n\n* Adult (18+ years old)\n* disordered eating\n* live in the United States of America\n\nExclusion Criteria:\n\n* BMI below 18.5","100 Years",{"count":115,"type":20},111,[23],"This study is about testing a short program that uses social support to help people with disordered eating. The goal is to see if this program can help people build better habits and feel better about eating while reducing harmful symptoms. In the long run, this project wants to make it easier for people with eating problems to get help and recover, especially for those in rural areas or other groups who don't often get the care they need. Participants will complete self-report measures online, and complete a digital single-session program.",[119,120,121,122],"Eating Disorders (Excluding Anorexia Nervosa)","Disordered Eating","Disordered Eating Behaviors","Eating Disorder Symptom",[124,125],"eating disorder","disordered eating","2026-04-29",{"date":128,"type":34},"2026-05-01",{"date":130,"type":20},"2026-07-01",{"date":132,"type":20},"2027-06-30",{"name":40,"class":41},{"id":135,"slug":136,"hasResults":11,"nctId":137,"briefTitle":138,"officialTitle":138,"acronym":4,"eligibilityCriteria":139,"healthyVolunteers":11,"sex":16,"minAge":140,"maxAge":141,"enrollmentInfo":142,"targetDuration":4,"studyType":21,"phases":144,"briefSummary":145,"conditions":146,"keywords":4,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":156,"lastUpdatePostDateStruct":157,"startDateStruct":159,"completionDateStruct":161,"leadSponsor":163,"locationsCount":42},"100634461","evaluation-of-a-novel-indoor-air-pollution-intervention-among-older-adults-100634461","NCT07539987","Evaluation of a Novel Indoor Air Pollution Intervention Among Older Adults","Inclusion Criteria:\n\n* 55-79 years of age one primary residence (5+ days per week)\n* have an electronic device, email address, and reliable internet at home for survey submission\n\nExclusion Criteria:\n\n* current smoking of any kind or living in a household with someone who currently smokes\n* current use of a portable air cleaner unit at home\n* plans to move in the next year\n* previous physician-diagnosed cardiovascular disease (coronary heart disease \\[myocardial infarction\\], stroke, or heart failure)","55 Years","79 Years",{"count":143,"type":20},154,[23],"Particulate matter air pollution is the leading environmental risk factor of cardiovascular disease and is increasing in the Western United States due to more frequent and severe wildfires. Older adults are particularly susceptible to both air pollution exposures and the development of cardiovascular disease, and the older adult population in the United States is rapidly growing. Given the converging threats of worsening air quality and an aging population, this clinical trial will evaluate a novel, multifaceted indoor air quality intervention to improve cardiovascular health outcomes among older adults in the wildfire-impacted state of Montana.",[147,148,149,150,151,152,153,154,155],"Cardiovascular Diseases","Blood Pressure","Glycated Hemoglobin (HbA1c)","Cholesterol","Cholesterol, HDL","Cholesterol, LDL","Indoor Air Quality","Particulate Matter","Health Behavior","2026-04-13",{"date":158,"type":34},"2026-04-20",{"date":160,"type":20},"2026-08",{"date":162,"type":20},"2030-07",{"name":40,"class":41},{"id":165,"slug":166,"hasResults":11,"nctId":167,"briefTitle":168,"officialTitle":169,"acronym":170,"eligibilityCriteria":171,"healthyVolunteers":15,"sex":16,"minAge":140,"maxAge":4,"enrollmentInfo":172,"targetDuration":4,"studyType":21,"phases":174,"briefSummary":175,"conditions":176,"keywords":180,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":183,"lastUpdatePostDateStruct":184,"startDateStruct":186,"completionDateStruct":188,"leadSponsor":190,"locationsCount":42},"100612523","the-food-for-health-study-100612523","NCT07254689","The Food for Health Study","A Produce Prescription Program Aimed at Reducing Food Insecurity and Type 2 Diabetes Risk Among Native American Older Adults","F4H","Inclusion Criteria:\n\n* Adults aged 55 years or older\n* Live on the Flathead Reservation\n* Self-identify as Native American (NA)\n* Food insecurity, as determined using Hunger Vital Sign™, a two question screener asked by providers.\n* Diabetes diagnosis\n* Pre-diabetic based on HbA1c lab results of (5.7-6.4%) or scores 5+ on the National Diabetes Prevention Programs screener based on health and history.\n\nExclusion Criteria:\n\n* Individuals with end-stage renal disease\n* Their health provider states they should not participate",{"count":173,"type":20},43,[23],"The project, called Food for Health (F4H), will study a new Produce Prescription Program (PPP) designed for rural Native American older adults. The study is based in the Confederated Salish and Kootenai Tribes (CSKT) of the Flathead Indian Reservation in Montana. In this community, many older adults face food insecurity and higher risk for Type 2 Diabetes (T2D). The tribal health department (THD) and local Food Resource Center (FRC) already provide important health and food support services, and this project builds on these strengths.\n\nProduce Prescription Programs (PPPs) is a type of nutrition support intervention that connects healthcare providers with local food programs to help patients access fresh, healthy foods. For example, an individual enrolled in the study will be \"prescribe\" fruits and vegetables in the form of a vouchers or coupons, which can be used to buy these foods at local food centers. Research shows that this type of program can reduce food insecurity, improve diet, and support better health. PPPs also fit well with tribal community priorities by supporting food sovereignty, culture-based nutrition education, and a stronger local food system.\n\nA key part of the study approach is using Community-Based Participatory Research (CBPR). CBPR means that community members, health providers, and researchers work together as equal partners. This way, the program is not just designed \"for\" the community, but \"with\" the community. The CSKT THD and community members have been involved in shaping this project from the start, and their priorities-like food security and food sovereignty-are at the center of the work.\n\nThe investigators will carry out the study in two phases.\n\nPhase 1: Investigators will pilot test the acceptability of F4H in a small group of older adults (N=10) to understand the program's acceptability. The results will be used to refine and improve the program before moving to the next phase.\n\nPhase 2: Investigators will test the feasibility and impact of the refined F4H program with a larger group of older adults (N=33). Participant food insecurity and T2D risk factors, such as blood sugar and weight, will be measured before and after the program. Investigators expect that participants will have less food insecurity and healthier measures after completing the program.\n\nThe clinic-to-community model is central to F4H. The THD will provide the prescriptions, and the FRC will be where participants redeem vouchers for fruits, vegetables, and other nutritious foods. The program will also include nutrition education that is grounded in Native culture and values. This model helps strengthen connections between healthcare and community services, creating a more supportive system for older adults.\n\nIn addition to testing the program, investigators will study how it is carried out. This is called implementation research. It means paying attention to how the program fits into the community setting, what helps it succeed, and what barriers might need to be addressed. Understanding these factors is important so that the program can continue in the future and potentially be expanded to other Native communities.\n\nThe long-term goal of F4H is to empower Native American communities to improve nutrition and reduce health disparities. By supporting older adults in gaining better access to healthy foods, the aim is to lower diabetes risk, improve quality of life, and strengthen local food systems. If the program is successful, it can serve as a model for other rural communities facing similar challenges.",[177,178,179],"Type 2 Diabetes","Food Insecurity","Rural Health",[181,182],"produce prescription program","Native American","2026-04-02",{"date":185,"type":34},"2026-04-03",{"date":187,"type":34},"2026-04-01",{"date":189,"type":20},"2028-09-30",{"name":40,"class":41},{"id":192,"slug":193,"hasResults":11,"nctId":194,"briefTitle":195,"officialTitle":196,"acronym":4,"eligibilityCriteria":197,"healthyVolunteers":15,"sex":16,"minAge":198,"maxAge":199,"enrollmentInfo":200,"targetDuration":4,"studyType":21,"phases":202,"briefSummary":203,"conditions":204,"keywords":206,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":212,"lastUpdatePostDateStruct":213,"startDateStruct":215,"completionDateStruct":217,"leadSponsor":218,"locationsCount":42},"100494617","preliminary-testing-of-cafe-move-for-primary-prevention-of-physical-frailty-100494617","NCT05720507","Preliminary Testing of Cafe Move for Primary Prevention of Physical Frailty","Cafe Move: A Novel Program for Prevention of Age-Related Physical Frailty","Inclusion Criteria:\n\n* Legally autonomous to consent\n* Lives independently\n* Ability to sit, stand, and walk without the assistance of another person\n\nExclusion Criteria:\n\n* Not legally autonomous to consent\n* Institutionalized","50 Years","85 Years",{"count":201,"type":20},36,[23],"This project explores a novel means of health promotion and prevention of age-related physical frailty, which is designed to overcome barriers to access and promote autonomy in managing physical health.",[205],"Aging",[207,208,209,210,211],"Frailty","Physical function","Strength","Mobility","Balance","2026-02-02",{"date":214,"type":34},"2026-02-05",{"date":216,"type":34},"2023-04-29",{"date":38,"type":20},{"name":40,"class":41},{"id":220,"slug":221,"hasResults":11,"nctId":222,"briefTitle":223,"officialTitle":223,"acronym":4,"eligibilityCriteria":224,"healthyVolunteers":15,"sex":225,"minAge":17,"maxAge":4,"enrollmentInfo":226,"targetDuration":4,"studyType":21,"phases":228,"briefSummary":229,"conditions":230,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":241,"lastUpdatePostDateStruct":242,"startDateStruct":244,"completionDateStruct":246,"leadSponsor":248,"locationsCount":42},"100497921","understanding-the-role-of-doulas-in-supporting-people-with-pmads-100497921","NCT05763537","Understanding the Role of Doulas in Supporting People With PMADs","Inclusion Criteria:\n\n* Participants must be over the age of 18\n* Currently pregnant and between 13 and 26 gestational weeks at the time of enrollment\n* Live in a HRSA-designated rural area of Montana\n\nExclusion Criteria:\n\n* They are under the age of 18\n* Not currently pregnant\n* Not between 13-26 gestational weeks at the time of enrollment\n* If they do not live in a HRSA-designated rural are of Montana.","FEMALE",{"count":227,"type":20},75,[23],"Detailed Description The doula-led intervention developed during the first phase of this project will be pilot tested for feasibility. Following the recruitment procedures described in the recruitment and retention plan, approximately 75 participants will be enrolled into the study. Twenty-five of the participants will receive regular doula care and 25 of the participants will receive care from a doula trained in the PMAD doula training throughout their pregnancy, childbirth, and postpartum time period, following the intervention procedures developed in Aim 2 of this study. Twenty-five women will not receive care from a doula and will receive perinatal care as usual. Women in all groups will take surveys via REDCap during their enrollment in the intervention, at 1 month postpartum, 3 months, and 6 months postpartum (at the conclusion of the intervention). All participants who receive the PMAD doula intervention will complete checklists after each session with their doula, to assess fidelity to the intervention. Participant communication with their doula via patient notebook will also be assessed for fidelity to the intervention.",[231,232,233,234,235,236,237,238,239,240],"Maternal Health","Pregnancy","Delivery, Obstetric","Self Efficacy","Social Support","Mental Health","Substance-Related Disorders","Postpartum Depression","Depression","Mental Health Services","2025-11-12",{"date":243,"type":34},"2025-11-14",{"date":245,"type":34},"2024-11-26",{"date":247,"type":20},"2026-07-31",{"name":40,"class":41},{"id":250,"slug":251,"hasResults":11,"nctId":252,"briefTitle":253,"officialTitle":254,"acronym":255,"eligibilityCriteria":256,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":257,"targetDuration":4,"studyType":21,"phases":259,"briefSummary":260,"conditions":261,"keywords":263,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":271,"lastUpdatePostDateStruct":272,"startDateStruct":274,"completionDateStruct":276,"leadSponsor":278,"locationsCount":279},"100515036","improving-psychological-and-vestibular-health-mindgaps-100515036","NCT05986279","Improving Psychological and Vestibular Health: MINDGAPS","Improving Psychological and Vestibular Health Using a Novel Intervention: The Making Informed Decisions in Gaze and Postural Stability (MINDGAPS) System","MINDGAPS","Inclusion Criteria:\n\n* Veteran or Active Duty Military Service Member\n* Ability to stand independently\n* Legally autonomous and able to self-consent\n\nExclusion Criteria:\n\n* Acute head injury (within the previous 2 months)\n* History of moderate or severe head injury (i.e., loss of consciousness greater than 30 minutes or post-traumatic amnesia greater than 1 day)\n* Current diagnosis of spine disorders in the neck\n* Diagnosis of problems with the arteries in your neck\n* Blindness\n* If you have been diagnosed with abnormal eye movements (also called \"ocular motor palsy\")\n* If you have previously had a stroke or been diagnosed with a neurodegenerative disorder ( e.g., Parkinson's Disease, Multiple Sclerosis)\n* If you have been previously diagnosed primary vestibular dysfunction ( e.g., congenital peripheral vestibular syndrome)\n* If you have previously been diagnosed with a brain tumor\n* If you are currently receiving physical therapy care for balance or dizziness problems",{"count":258,"type":20},500,[23],"The purpose of this study is twofold: 1) Develop norms for measures of inner ear function and psychological health, and 2) Examine the feasibility of using the MINDGAPS system (a remote monitoring system) to track progress during physical therapy or rehabilitation for inner ear problems following a concussion or mild Traumatic Brain Injury.",[262],"Vestibular Hypofunction",[264,265,266,267,268,269,270],"Rehabilitation","mild traumatic brain injury","dynamic visual acuity","gaze stability","postural stability","dizziness","psychological health","2024-12-03",{"date":273,"type":34},"2024-12-06",{"date":275,"type":34},"2023-08-30",{"date":277,"type":20},"2027-09-29",{"name":40,"class":41},2,{"id":281,"slug":282,"hasResults":11,"nctId":283,"briefTitle":284,"officialTitle":285,"acronym":4,"eligibilityCriteria":286,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":287,"targetDuration":4,"studyType":21,"phases":289,"briefSummary":291,"conditions":292,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":293,"lastUpdatePostDateStruct":294,"startDateStruct":296,"completionDateStruct":298,"leadSponsor":300,"locationsCount":42},"100570401","early-phase-1-group-telehealth-behavioral-cough-suppression-therapy-100570401","NCT06706765","Group Telehealth Behavioral Cough Suppression Therapy","Group Telehealth Behavioral Cough Suppression Therapy Pilot Study","Inclusion Criteria:\n\n* At least 18 years old\n* Predominantly dry cough for at least 8 weeks\n* Evaluated and treated by at least one physician for cough\n* Obtained a chest X-ray or chest CT scan specifically related to the cough with unremarkable results\n* Access to a computer or tablet that includes a camera and able to use the device independently\n* Reliable internet access\n* Willing to agree to maintain confidentiality of personal information (including names) related to others in the study\n\nExclusion Criteria:\n\n* Under age 18\n* Coughing up blood\n* Current smoker of any substance\n* History of smoking or 10 or more years\n* Diagnosed with a chronic lung condition (e.g., COPD, emphysema, lung cancer, idiopathic pulmonary fibrosis, chronic bronchitis, asthma)? (NOTE: If a patient has been told their cough may be (or is likely) due to asthma but they have not had any formal lung testing and asthma treatments have not helped your cough, we don't consider this a formal asthma diagnosis and will not exclude them from the study.)\n* Diagnosed currently or in the past with head and neck cancer (i.e., cancer of the mouth, nose, or throat).\n* Complaints of swallowing difficulty\n* Taking any of the following medications, which have a known side effect of cough: Benzapril (Lotensin), Captopril (Capoten), Enalapril\u002FEnalaprilat (Vasotec oral and injectable), Fosinopril (Monopril), Lisinopril (Zestril and Prinivil), Moexipril (Univasc), Perindopril (Aceon), Quinapril (Accupril), Ramipril (Altace), and Trandolapril (Mavik)\n* Prior BCST treatment with an SLP or respiratory therapist",{"count":288,"type":20},60,[290],"EARLY_PHASE1","The purpose of this study is to investigate the effectiveness of behavioral cough suppression therapy (BCST) in managing refractory chronic cough (RCC) within a group telehealth setting. RCC is a cough that has lasted at least 8 weeks and has not resolved with standard medical treatment. BCST is a research-based treatment provided by specialty-trained speech-language pathologists (SLPs) for patients with RCC. Although the treatment works very well for a large proportion of patients in a standard one-on-one format, there are a limited number of SLPs available to provide this treatment and patients living in rural areas do not typically have access to an SLP trained in BCST. If BCST can effectively be delivered in a group telehealth model, it would significantly improve accessibility to the treatment.",[58],"2024-11-25",{"date":295,"type":34},"2024-11-27",{"date":297,"type":34},"2024-03-22",{"date":299,"type":20},"2025-01-31",{"name":40,"class":41},""]